last posts

Global Pharmaceutical and Biopharmaceutical Contract Manufacturing Market Report 2023: Increased Investment in Advanced Manufacturing Technologies to Fuel Growth - ResearchAndMarkets.com

techsm5

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical and Biopharmaceutical Contract Manufacturing Market – Global industry size, share, trends, opportunities and forecast, 2018-2028 by sector (pharmaceutical, biopharmaceutical), by product type, by service, by Drug Type, By Region, Forecast and Opportunity, 2028 report has been added to from ResearchAndMarkets.com offer.

The global pharmaceutical and biopharmaceutical contract manufacturing market is expected to register significant growth during the forecast period 2024-2028. The growing emphasis on contract manufacturing companies to expand their biologic drug manufacturing capabilities, along with the establishment of new services to meet the growing demand from biopharmaceutical companies, is expected to drive the growth of the market.

Also, increasing investment in advanced manufacturing technologies by contract development and manufacturing organizations (CDMOs) is a major factor, which is expected to drive the market growth in the coming years. Additionally, the increase in drug development and manufacturing activities by pharmaceutical companies is propelling the growth of the global pharmaceutical and biopharmaceutical contract manufacturing market.

For example, in 2022, INCOG BioPharma Services, the Indiana-based contract development and manufacturing organization (CDMO) specializing in sterile injectables, disclosed that the construction of its manufacturing facility and global headquarters in Fishers was almost over.

Contract manufacturing is a form of outsourcing where a manufacturing company enters into an agreement with another manufacturing company to develop innovative products and services.

The global pharmaceutical and biopharmaceutical contract manufacturing market is segmented into industry, product type, service, drug type, company, and region. Based on service type, the market is segmented into pharmaceutical manufacturing services, biologics manufacturing services, and drug development services. Pharmaceutical manufacturing services are further segmented into pharmaceutical API manufacturing services and pharmaceutical FDF manufacturing services. Similarly, Biologics Manufacturing Services is segmented into Biologics FDF Manufacturing Services and Biologics API Manufacturing Services. Among these, pharmaceutical manufacturing services hold the largest market share and are expected to witness the fastest growth over the forecast period. This is attributed to the increasing number of sterile formulations and intensive drug development activities.

According to the region, Asia-Pacific is expected to register the fastest growth over the forecast period owing to improved healthcare infrastructure and availability of highly skilled labor force. Many pharmaceutical companies locate their manufacturing units in countries like China and India, due to low manufacturing and operating costs. Hence, making Asian countries the hub of outsourcing.

Report Scope:

Global Pharmaceutical and Biopharmaceutical Contract Manufacturing Market, By Sector:

  • Pharmaceutical

  • Biopharmaceutical

Global Pharmaceutical and Biopharmaceutical Contract Manufacturing Market, By Product Type:

  • Active Pharmaceutical Ingredients (API)

  • Finished dosage formulation

  • Tablet

  • Capsule

  • Oral fluids

  • Parenteral/Injectables

  • Others

  • Advanced Drug Delivery Products

  • Over-the-counter (OTC) drugs

  • nutritional products

  • Others

Global Pharmaceutical and Biopharmaceutical Contract Manufacturing Market, By Service:

  • Pharmaceutical Manufacturing Services

  • Pharmaceutical API Manufacturing Services

  • Pharmaceutical FDF Manufacturing Services

  • Biologics Manufacturing Services

  • Biologics FDF Manufacturing Services

  • Biologics API Manufacturing Services

  • Drug Development Services

Global Pharmaceutical and Biopharmaceutical Contract Manufacturing Market, By Drug Type:

  • Creator / Patentee

  • Generics

  • Biosimilar

Global Pharmaceutical and Biopharmaceutical Contract Manufacturing Market, By Region:

  • Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Europe

  • France

  • Germany

  • UK

  • Italy

  • Spain

  • North America

  • United States

  • Mexico

  • Canada

  • South America

  • Brazil

  • Argentina

  • Colombia

  • Middle East and Africa

  • United Arab Emirates

  • South Africa

  • Saudi Arabia

Main topics covered:

1. Product introduction

2. Research methodology

3. Executive Summary

4. Voice of the customer

5. Global Pharmaceutical and Biopharmaceutical Contract Manufacturing Market Outlook

6. Asia-Pacific Pharmaceutical and Biopharmaceutical Contract Manufacturing Market Outlook

7. Europe Contract Manufacturing of Pharmaceuticals Market Outlook

8. North America Pharmaceutical Contract Manufacturing Market Outlook

9. South America Pharmaceutical Contract Manufacturing Market Outlook

10. Middle East & Africa Pharmaceuticals Contract Manufacturing Market Outlook

11. Market dynamics

12. Market trends and developments

13. Competitive Landscape

14. Strategic Recommendations

Companies cited

  • Jubilant Pharmova Limited

  • JRS PHARMA GmbH & Co.

  • Boehringer Ingelheim GmbH

  • Lonza Group

  • Rentschler Biotechnology GmbH

  • Inno Biologics Sdn Bhd

  • INCOG Biopharmaceutical Services

  • Baxter BioPharma Solutions

  • Catalent Pharmaceutical Solutions

  • Kemwell Biopharma Private Limited

For more information on this report visit https://www.researchandmarkets.com/r/fm79u5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

techsm5

Comments



Font Size
+
16
-
lines height
+
2
-